As for factors that may favor infectivity in cancer patients, the most obvious ones to consider are the cell surface ACE2 (the SARS-CoV2 receptor) and TMPRSS2 (the enzyme that processes the Spike protein to facilitate the cellular entry of SARS-CoV2). The gene discussed is ACE2; the disease is cancer.